INVITRO STUDIES OF HUMAN PLASMA LIPOLYTIC ACTIVITY BEFORE AND AFTER ORAL FAT INTAKE

[1] BAEDER DH, 1956, FED PROC, V15, P396

[2] BORGSTROM B, 1952, Acta Physiol Scand, V25, P328, DOI 10.1111/j.1748-1716.1952.tb00885.x

[3] INVIVO EFFECT OF ANTI-HEPARIN AGENTS ON SERUM LIPIDS AND LIPOPROTEINS [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1954, 177 (01): : 128 - 133

[4] HUMAN ENDOGENOUS LIPEMIA CLEARING FACTOR (ACTIVE FACTOR) [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1955, 181 (02): : 309 - 312

[5] ENGELBERG H, 1956, J BIOL CHEM, V22, P60

[6] ENGELBERG H, UNPUBLISHED

[7] GROSSMAN MI, 1954, J LAB CLIN MED, V43, P445

[8] GROSSMAN MI, 1954, B ARMY MED NUTRITION, V140

[9] THE EFFECT OF HEPARIN AND PROTAMINE SULPHATE ON THE OCCURRENCE OF CHYLOMICRONS IN HUMAN BLOOD [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1953, 5 (03) : 241 - 249

[10] METABOLISM OF CHYLOMICRA .1. REMOVAL OF PALMITIC ACID-1-C-14 LABELED CHYLOMICRA FROM DOG PLASMA [J]. JOURNAL OF CLINICAL INVESTIGATION, 1956, 35 (09) : 1025 - 1032

[1] BAEDER DH, 1956, FED PROC, V15, P396

[2] BORGSTROM B, 1952, Acta Physiol Scand, V25, P328, DOI 10.1111/j.1748-1716.1952.tb00885.x

[3] INVIVO EFFECT OF ANTI-HEPARIN AGENTS ON SERUM LIPIDS AND LIPOPROTEINS [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1954, 177 (01): : 128 - 133

[4] HUMAN ENDOGENOUS LIPEMIA CLEARING FACTOR (ACTIVE FACTOR) [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1955, 181 (02): : 309 - 312

[5] ENGELBERG H, 1956, J BIOL CHEM, V22, P60

[6] ENGELBERG H, UNPUBLISHED

[7] GROSSMAN MI, 1954, J LAB CLIN MED, V43, P445

[8] GROSSMAN MI, 1954, B ARMY MED NUTRITION, V140

[9] THE EFFECT OF HEPARIN AND PROTAMINE SULPHATE ON THE OCCURRENCE OF CHYLOMICRONS IN HUMAN BLOOD [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1953, 5 (03) : 241 - 249

[10] METABOLISM OF CHYLOMICRA .1. REMOVAL OF PALMITIC ACID-1-C-14 LABELED CHYLOMICRA FROM DOG PLASMA [J]. JOURNAL OF CLINICAL INVESTIGATION, 1956, 35 (09) : 1025 - 1032